2021 / 03

Next Paper
DOI: 10.47183/mes.2021.021
Copyright: © 2021 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

CLINICAL CASE

Central vein sign for differential diagnosis of demyelinating diseases of CNS

Belov SE1,2, Gubsky IL2, Lelyuk VG2, Boyko AN1,2
About authors

1 Pirogov Russian National Research Medical University, Moscow, Russia

2 Federal Center for Brain Research and Neurotechnologies of FMBA, Moscow, Russia

Correspondence should be addressed: Alexey N. Boyko
Ostrovityanova, 1, 117437, Москва; moc.liamg@31naokyob

About paper

Author contribution: Belov SE — literature analysis, study design, recruitment of patients, clinical analysis, manuscript preparation; Gubsky IL — study design, MRI examinations, MRI data analysis, manuscript preparation; Lelyuk VG — study design, MRI data analysis, manuscript preparation; Boyko AN — study design, recruitment of patients, clinical analysis, manuscript preparation.

Compliance with ethical standards: informed consent was obtained from both patients.

Received: 2021-07-15 Accepted: 2021-08-04 Published online: 2021-08-18
|
  1. Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018; 17 (2): 162–73. DOI: 10.1016/S1474-4422(17)30470-2.
  2. Solomon AJ. Diagnosis, Differential Diagnosis, and Misdiagnosis of Multiple Sclerosis. Continuum (Minneap Minn). 2019; 25 (3): 611–35. DOI: 10.1212/CON.0000000000000728.
  3. Solomon AJ, Klein EP, Bourdette D. "Undiagnosing" multiple sclerosis: the challenge of misdiagnosis in MS. Neurology. 2012; 78 (24): 1986–91. DOI: 10.1212/WNL.0b013e318259e1b2.
  4. Clarke MA, Pareto D, Pessini-Ferreira L, et al. Value of 3T Susceptibility-Weighted Imaging in the Diagnosis of Multiple Sclerosis. Am J Neuroradiol. 2020; 41 (6): 1001–8 DOI: 10.3174/ ajnr.A6547.
  5. Oh J, Sicotte NL. New imaging approaches for precision diagnosis and disease staging of MS? Mult Scler. 2020; 26 (5): 568–75. DOI: 10.1177/1352458519871817.
  6. Tallantyre EC, Brookes MJ, Dixon JE, Morgan PS, Evangelou N, Morris PG. Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI. Neurology. 2008; 70: 2076–8. DOI: 10.1212/01.wnl.0000313377.49555.2e.
  7. Tallantyre EC, Dixon JE, Donaldson I, Owens T, Morgan P S, Morris PG, Evangelou N. Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions. Neurology. 2011; 76: 534–9 DOI: 10.1212/WNL.0b013e31820b7630.
  8. Mistry N, Dixon J, Tallantyre E, Tench C, Abdel-Fahim R, Jaspan T, Morgan PS, Morris P, Evangelou N. Central veins in brain lesions visualized with high-field magnetic resonance imaging: a pathologically specific diagnostic biomarker for inflammatory demyelination in the brain. JAMA Neurol. 2013; 70 (5): 623–8 DOI: 10.1001/jamaneurol.2013.1405.
  9. Maggi P, Absinta M, Grammatico M, et al. Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies. Ann Neurol. 2018; 83 (2): 283–94 DOI: 10.1002/ana.25146.
  10. Maggi P, Absinta M, Sati P, et al. The "central vein sign" in patients with diagnostic "red flags" for multiple sclerosis: A prospective multicenter 3T study. Mult Scler. 2020; 26 (4): 421–32 DOI: 10.1177/1352458519876031.
  11. Campion T, Smith RJP, Altmann DR, et al. FLAIR* to visualize veins in white matter lesions: A new tool for the diagnosis of multiple sclerosis? Eur Radiol. 2017; 27 (10): 4257–63. DOI: 10.1007/s00330-017-4822-z.
  12. Clarke MA, Samaraweera AP, Falah Y, et al. Single Test to ARrive at Multiple Sclerosis (STAR-MS) diagnosis: A prospective pilot study assessing the accuracy of the central vein sign in predicting multiple sclerosis in cases of diagnostic uncertainty. Mult Scler. 2020; 26 (4): 433–41. DOI: 10.1177/1352458519882282.
  13. Cortese R, Magnollay L, Tur C, et al. Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD. Neurology. 2018; 90 (14): e1183-e1190. DOI: 10.1212/WNL.0000000000005256.
  14. Sparacia G, Agnello F, Gambino A, Sciortino M, Midiri M. Multiple sclerosis: High prevalence of the 'central vein' sign in white matter lesions on susceptibility-weighted images. Neuroradiol J. 2018; 31 (4): 356–61. DOI: 10.1177/1971400918763577.
  15. Suh CH, Kim SJ, Jung SC, Choi CG, Kim HS. The "Central Vein Sign" on T2*-weighted Images as a Diagnostic Tool in Multiple Sclerosis: A Systematic Review and Meta-analysis using Individual Patient Data. Sci Rep. 2019; 9 (1): 18188. DOI: 10.1038/s41598019-54583-3.
  16. Sinnecker T, Clarke MA, Meier D, et al. Evaluation of the central vein sign as a diagnostic imaging biomarker in multiple sclerosis. JAMA Neurol. 2019; 76 (12): 1446–56. DOI: 10.1001/ jamaneurol.2019.2478.
  17. Bhandari A, Xiang H, Lechner-Scott J, Agzarian M. Central vein sign for multiple sclerosis: A systematic review and meta-analysis. Clin Radiol. 2020; 75 (6): 479.e9–479.e15. DOI: 10.1016/j. crad.2020.01.011.
  18. Gaitán MI, Yañez P, Paday Formenti ME, Calandri I, Figueiredo E, Sati P, et al. SWAN-Venule: An Optimized MRI Technique to Detect the Central Vein Sign in MS Plaques. Am J Neuroradiol. 2020; 41 (3): 456–60. DOI: 10.3174/ajnr.A6437.
  19. Sati P, Oh J, Constable RT, Evangelou N, Guttmann CR, Henry RG, et al. NAIMS Cooperative. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nat Rev Neurol. 2016; 12 (12): 714–22. DOI: 10.1038/nrneurol.2016.166.
  20. Belov SE, Boyko AN. The symptom of the central vein in the differential diagnosis of multiple sclerosis. Neurology, Neuropsychiatry, Psychosomatics, 2020, 12 (Suppl. 1): 29–32. Russian.